Qingqing Ding

9.3k total citations · 3 hit papers
89 papers, 4.3k citations indexed

About

Qingqing Ding is a scholar working on Molecular Biology, Cancer Research and Materials Chemistry. According to data from OpenAlex, Qingqing Ding has authored 89 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 19 papers in Cancer Research and 14 papers in Materials Chemistry. Recurrent topics in Qingqing Ding's work include Covalent Organic Framework Applications (10 papers), Scheduling and Optimization Algorithms (8 papers) and Advanced Manufacturing and Logistics Optimization (7 papers). Qingqing Ding is often cited by papers focused on Covalent Organic Framework Applications (10 papers), Scheduling and Optimization Algorithms (8 papers) and Advanced Manufacturing and Logistics Optimization (7 papers). Qingqing Ding collaborates with scholars based in China, United States and Taiwan. Qingqing Ding's co-authors include T.C.E. Cheng, Bertrand M.T. Lin, Mien‐Chie Hung, Weiya Xia, Dung‐Fang Lee, Chien‐Chen Lai, Jer-Yen Yang, Longfei Huo, Shouyu Wang and Zhangding Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Qingqing Ding

87 papers receiving 4.2k citations

Hit Papers

METTL3-mediated m 6 A mod... 2003 2026 2010 2018 2019 2003 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingqing Ding China 28 2.2k 870 760 747 357 89 4.3k
Jing Ma China 27 2.2k 1.0× 558 0.6× 349 0.5× 67 0.1× 44 0.1× 150 3.5k
Kyung‐Sup Kim South Korea 39 2.7k 1.2× 898 1.0× 432 0.6× 188 0.3× 13 0.0× 173 6.7k
Xiao‐Feng Sun Sweden 44 3.2k 1.4× 1.8k 2.0× 1.9k 2.5× 90 0.1× 12 0.0× 237 6.3k
Jingquan Li China 32 1.6k 0.7× 556 0.6× 845 1.1× 45 0.1× 11 0.0× 125 3.9k
Snigdha Banerjee United States 36 1.6k 0.7× 475 0.5× 620 0.8× 76 0.1× 6 0.0× 104 2.9k
Liping Jiang China 31 1.2k 0.5× 477 0.5× 193 0.3× 228 0.3× 5 0.0× 137 2.9k
Stephen L. Abrams United States 33 3.4k 1.5× 945 1.1× 1.5k 2.0× 17 0.0× 39 0.1× 95 5.3k
Andrew Silver United Kingdom 37 1.8k 0.8× 776 0.9× 909 1.2× 50 0.1× 8 0.0× 100 3.7k
Nariaki Fujimoto Japan 28 683 0.3× 319 0.4× 242 0.3× 14 0.0× 132 0.4× 140 3.0k

Countries citing papers authored by Qingqing Ding

Since Specialization
Citations

This map shows the geographic impact of Qingqing Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingqing Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingqing Ding more than expected).

Fields of papers citing papers by Qingqing Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingqing Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingqing Ding. The network helps show where Qingqing Ding may publish in the future.

Co-authorship network of co-authors of Qingqing Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Qingqing Ding. A scholar is included among the top collaborators of Qingqing Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingqing Ding. Qingqing Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Lan, Georges Tabet, Charles C. Guo, et al.. (2025). Clinicopathological study of 34 cases of clear cell adenocarcinoma of the urinary tract and diagnostic value of SOX 17 in its differential diagnosis. Human Pathology. 157. 105767–105767. 1 indexed citations
2.
Wang, Chan, Jiang Jiang, Yu Han, et al.. (2025). Protein Coronation-Induced Cancer Staging-Dependent Multilevel Cytotoxicity: An All-Humanized Study in Blood Vessel Organoids. ACS Nano. 19(1). 345–368. 1 indexed citations
3.
Liu, Yuting, et al.. (2025). Multirobot conflict coordination and dynamic obstacle avoidance cooperative path planning. Intelligent Service Robotics. 18(3). 413–432. 1 indexed citations
4.
Wu, Yun, Constance T. Albarracin, Lavinia P. Middleton, et al.. (2024). A Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland. Human Pathology. 145. 42–47. 7 indexed citations
6.
Chen, Hui, et al.. (2023). Room temperature synthesis of flower-like hollow covalent organic framework for efficient enrichment of microcystins. RSC Advances. 13(7). 4255–4262. 11 indexed citations
7.
Yu, Ruoying, Qiuxiang Ou, Hua Bao, et al.. (2022). Clinical and molecular characteristics of kinase domain duplications across diverse cancer types in the Chinese population. Cancer Medicine. 12(5). 6009–6015. 3 indexed citations
8.
Lu, Qiaomei, Qingqing Ding, Huiling Zhang, et al.. (2022). An agaric-like covalent organic framework composite for efficient extraction of trace cytokinins in plant samples. Journal of Chromatography A. 1683. 463524–463524. 7 indexed citations
9.
Yang, Jun, Yuan Liu, Yu Zhang, et al.. (2021). PGE2-JNK signaling axis non-canonically promotes Gli activation by protecting Gli2 from ubiquitin-proteasomal degradation. Cell Death and Disease. 12(7). 707–707. 9 indexed citations
10.
Lv, Zhanyun, Lifang Wang, Kui Zhang, et al.. (2021). RNA-sequencing of peripheral blood circular RNAs in Parkinson disease. Medicine. 100(23). e25888–e25888. 29 indexed citations
11.
Yan, Caixia, Huimin Guo, Qingqing Ding, et al.. (2020). Multiomics Profiling Reveals Protective Function of Schisandra Lignans against Acetaminophen-Induced Hepatotoxicity. Drug Metabolism and Disposition. 48(10). 1092–1103. 13 indexed citations
12.
Wang, Qiang, Chen Chen, Qingqing Ding, et al.. (2019). METTL3-mediated m 6 A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut. 69(7). 1193–1205. 629 indexed citations breakdown →
13.
Zhang, Xudong, Yuxin Wang, Manman Xie, et al.. (2018). Downregulating Heparanase-Induced Vascular Normalization: A New Approach To Increase the Bioavailability of Chemotherapeutics in Solid Tumors. Molecular Pharmaceutics. 15(9). 4303–4309. 2 indexed citations
14.
Ding, Qingqing. (2017). Advances in the diagnosis and treatment of breast cancer in the elderly. Zhonghua laonian yixue zazhi. 36(12). 1386–1389. 1 indexed citations
15.
Ding, Qingqing, et al.. (2015). Value of methylated Septin 9 detection in screening colorectal cancer in elderly people. Zhonghua laonian yixue zazhi. 34(12). 1348–1350. 4 indexed citations
16.
Li, Chia‐Wei, Weiya Xia, Longfei Huo, et al.. (2012). Epithelial–Mesenchymal Transition Induced by TNF-α Requires NF-κB–Mediated Transcriptional Upregulation of Twist1. Cancer Research. 72(5). 1290–1300. 389 indexed citations
17.
Sun, Hui-Lung, An‐Chi Tsai, Shiow‐Lin Pan, et al.. (2009). EPOX Inhibits Angiogenesis by Degradation of Mcl-1 through ERK Inactivation. Clinical Cancer Research. 15(15). 4904–4914. 20 indexed citations
18.
Ding, Qingqing, Longfei Huo, Jer-Yen Yang, et al.. (2008). Down-regulation of Myeloid Cell Leukemia-1 through Inhibiting Erk/Pin 1 Pathway by Sorafenib Facilitates Chemosensitization in Breast Cancer. Cancer Research. 68(15). 6109–6117. 163 indexed citations
19.
Ding, Qingqing, Weiya Xia, Jer-Yen Yang, et al.. (2005). Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin. Molecular Cell. 19(2). 159–170. 507 indexed citations breakdown →
20.
Cheng, T.C.E. & Qingqing Ding. (1998). The complexity of single machine scheduling with two distinct deadlines and identical decreasing rates of processing times. Computers & Mathematics with Applications. 35(12). 95–100. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026